AskTheDate.com
Back to calendar

Coherus Oncology, Inc. (CHRS) Earnings

CHRS reports earnings on Wednesday, August 5, 2026

earnings report
August 5, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.20
Actual EPS: $-0.22
EPS surprise: 12.00%
Company overview
Market Cap$180.8M
PriceUSD 1.17
EPS (TTM)-1.02
52-week high2.62
52-week low0.95
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees147